• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/24

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

24 Cards in this Set

  • Front
  • Back
235. Tx of Idiopathic inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis)?
a. Corticosteroids are the initial treatment.
i. Continue until symptoms improve
ii. Then taper very slowly (up to 2 years may be necessary)
b. immunosuppressive agents (for patients who do not respond steroids)
c. physical therapy
236. What 3 immunosuppressive agents are used for the Idiopathic inflammatory myopathies?
1. Methotrexate
2. Cyclophosphamide
3. Chlorambucil
237. In whom is Inclusion Body Myositis more common?
a. Men (elderly)
238. Presentation of Inclusion Body Myositis?
a. Insidious onset of slowly progressive proximal and distal weakness, often leads to delay in diagnosis.
b. There is early weakness and atrophy of quadriceps, forearm flexors, and tibialis anterior muscles.
c. Involvement is asymmetrical.
d. Facial weakness occurs in one third of patients, and dysphagia in one of patients.
239. In terms of DTRs, how is Inclusion Body Myositis different from polymyositis and dermatomyositis?
a. Patients can also have loss of deep tendon reflexes (nerves are not involved in polymyositis and dermatomyositis)
240. Are there extra-muscular manifestations with Inclusion Body Myositis?
a. Extra muscular manifestations are rare
241. Diagnosis and prognosis of Inclusion Body Myositis?
a. Diagnosis: slight elevation of CK levels (relatively low)
b. There is a poor response to therapy
242. Diagnostic criteria for polymyositis?
a. If 2 of first four ->Possible polymyositis
b. If 3 of first four -> probable polymyositis
c. if all four -> Definate polymyositis
1. Symmetric proximal muscle weakness.
2. Elevation in serum creatinine phosphokinase.
3. EMG findings of myopathy.
4. Biopsy evidence of myositis.
5. Characteristic rash of dermatomyositis
243. In whom is Polymyalgia Rheumatica primarily seen?
a. Usually occurs in elderly patients (rare before age 50).
b. The mean age of onset is 70.
c. More common in women.
244. Pathophysiology of Polymyalgia Rheumatica?
a. An autoimmune process may be responsible.
b. Possible genetic link (Association with HLA –DR4 allele).
245. Prognosis of Polymyalgia Rheumatica?
a. Self-limited disease -duration of one to two years
246. Clinical features of Polymyalgia Rheumatica?
a. Hip and shoulder muscle pain (bilateral)
b. constitutional symptoms are usually present: malaise, fever, depression, weight loss, and fatigue.
c. Joint swelling.
d. S/S of temporal arteritis (if present)
247. Features of hip and shoulder muscle pain with Polymyalgia Rheumatica?
a. Often begins abruptly (may be gradual)
b. Stiffness in shoulder and hip regions after Inactivity the most prominent symptom.
c. Pain occurs on movement
d. muscle strength is normal
e. Profound, morning stiffness is common
248. Features of joint swelling in Polymyalgia Rheumatica?
a. Up to 20% of patients have Synovitis in knees, wrists, work and joints (can be confused with RA)
b. Synovitis and tenosynovitis around the shoulder may lead to rotator cuff tendinitis or adhesive capsulitis.
249. Diagnosis of Polymyalgia Rheumatica?
a. Essentially a clinical diagnosis
b. ESR is usually elevated and he in diagnosis
c. Almost always > 50, frequently > 100
i. ESR correlates with disease activity
250. Treatment of Polymyalgia Rheumatica?
a. Corticosteroids!
b. Response usually occurs within 1 to 7 days.
c. Steroids are not curative, but are effective in suppressing inflammation until the disease resolves itself.
d. After 4 to 6 weeks, begin to taper slowly
e. Most patients (60-70%) can stop steroids within two years.
f. A few patients have symptoms for up to 10 years
251. note: about 10% of people with polymyalgia rheumatica develop temporal arteritis. Whereas up to 40 to 50% of people temporary rightists have coexisting polymyalgia rheumatica
251. note: about 10% of people with polymyalgia rheumatica develop temporal arteritis. Whereas up to 40 to 50% of people temporary rightists have coexisting polymyalgia rheumatica
245. Prognosis of Polymyalgia Rheumatica?
a. Self-limited disease -duration of one to two years
246. Clinical features of Polymyalgia Rheumatica?
a. Hip and shoulder muscle pain (bilateral)
b. constitutional symptoms are usually present: malaise, fever, depression, weight loss, and fatigue.
c. Joint swelling.
d. S/S of temporal arteritis (if present)
247. Features of hip and shoulder muscle pain with Polymyalgia Rheumatica?
a. Often begins abruptly (may be gradual)
b. Stiffness in shoulder and hip regions after Inactivity the most prominent symptom.
c. Pain occurs on movement
d. muscle strength is normal
e. Profound, morning stiffness is common
248. Features of joint swelling in Polymyalgia Rheumatica?
a. Up to 20% of patients have Synovitis in knees, wrists, work and joints (can be confused with RA)
b. Synovitis and tenosynovitis around the shoulder may lead to rotator cuff tendinitis or adhesive capsulitis.
249. Diagnosis of Polymyalgia Rheumatica?
a. Essentially a clinical diagnosis
b. ESR is usually elevated and he in diagnosis
c. Almost always > 50, frequently > 100
i. ESR correlates with disease activity
250. Treatment of Polymyalgia Rheumatica?
a. Corticosteroids!
b. Response usually occurs within 1 to 7 days.
c. Steroids are not curative, but are effective in suppressing inflammation until the disease resolves itself.
d. After 4 to 6 weeks, begin to taper slowly
e. Most patients (60-70%) can stop steroids within two years.
f. A few patients have symptoms for up to 10 years
251. note: about 10% of people with polymyalgia rheumatica develop temporal arteritis. Whereas up to 40 to 50% of people temporary rightists have coexisting polymyalgia rheumatica
251. note: about 10% of people with polymyalgia rheumatica develop temporal arteritis. Whereas up to 40 to 50% of people temporary rightists have coexisting polymyalgia rheumatica